ViroGates A/S
CSE:VIRO

Watchlist Manager

ViroGates A/S

CSE:VIRO

Watchlist

Dividends

Discount Rate

Price: 9.3 DKK 3.91% Market Closed

Market Cap: 59.9m DKK

Have any thoughts about
ViroGates A/S?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 9.3 DKK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

VIRO Alert

ViroGates A/S

9.3

+0.35 (+3.91%)

52 Week Range	5.4 9.3
Price Target

We'll email you a reminder when the closing price reaches DKK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

ViroGates A/S

What unique competitive advantages
does ViroGates A/S hold over its rivals?

What risks and challenges
does ViroGates A/S face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of ViroGates A/S.

What unique competitive advantages
does ViroGates A/S hold over its rivals?

What risks and challenges
does ViroGates A/S face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for ViroGates A/S.

Provide P/S
for ViroGates A/S.

Provide P/E
for ViroGates A/S.

Provide P/OCF
for ViroGates A/S.

Provide P/FCFE
for ViroGates A/S.

Provide P/B
for ViroGates A/S.

Provide EV/S
for ViroGates A/S.

Provide EV/GP
for ViroGates A/S.

Provide EV/EBITDA
for ViroGates A/S.

Provide EV/EBIT
for ViroGates A/S.

Provide EV/OCF
for ViroGates A/S.

Provide EV/FCFF
for ViroGates A/S.

Provide EV/IC
for ViroGates A/S.

Compare the intrinsic valuations
of ViroGates A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of ViroGates A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of ViroGates A/S compared to its peers.

Compare the P/E ratios
of ViroGates A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing ViroGates A/S with its peers.

Analyze the financial leverage
of ViroGates A/S compared to its main competitors.

Show all profitability ratios
for ViroGates A/S.

Provide ROE
for ViroGates A/S.

Provide ROA
for ViroGates A/S.

Provide ROIC
for ViroGates A/S.

Provide ROCE
for ViroGates A/S.

Provide Gross Margin
for ViroGates A/S.

Provide Operating Margin
for ViroGates A/S.

Provide Net Margin
for ViroGates A/S.

Provide FCF Margin
for ViroGates A/S.

Show all solvency ratios
for ViroGates A/S.

Provide D/E Ratio
for ViroGates A/S.

Provide D/A Ratio
for ViroGates A/S.

Provide Interest Coverage Ratio
for ViroGates A/S.

Provide Altman Z-Score Ratio
for ViroGates A/S.

Provide Quick Ratio
for ViroGates A/S.

Provide Current Ratio
for ViroGates A/S.

Provide Cash Ratio
for ViroGates A/S.

What is the historical Revenue growth
over the last 5 years for ViroGates A/S?

What is the historical Net Income growth
over the last 5 years for ViroGates A/S?

What is the current Free Cash Flow
of ViroGates A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for ViroGates A/S.

EV/IC
Enterprise Value to IC

8.5

Current

5.3

Median

1.9

Industry

Higher than median

Higher than industry value

Enterprise Value to Invested Capital (EV/IC) ratio is a valuation multiple that measures the dollars in Enterprise Value for each dollar of capital invested by shareholders and lenders.

EV/IC

8.5

Enterprise Value

56.5m DKK

Invested Capital

6.7m DKK

All Countries

Forward Multiples

			Market Cap	EV/IC
DK	V	ViroGates A/S CSE:VIRO	59.9m DKK	8.5
US		Abbott Laboratories NYSE:ABT	205.7B USD	3.4
US		Intuitive Surgical Inc NASDAQ:ISRG	184.5B USD	13.7
US		Stryker Corp NYSE:SYK	140.6B USD	3.9
US		Boston Scientific Corp NYSE:BSX	125.6B USD	3.8
IE		Medtronic PLC NYSE:MDT	114.7B USD	1.7
US		Becton Dickinson and Co NYSE:BDX	68.6B USD	1.8
DE		Siemens Healthineers AG XETRA:SHL	53.8B EUR	1.6
CN		Shenzhen Mindray Bio-Medical Electronics Co Ltd SZSE:300760	338.2B CNY	8.8
US		GE Healthcare Technologies Inc NASDAQ:GEHC	40.2B USD	1.7
US		Edwards Lifesciences Corp NYSE:EW	40B USD	5.7


DK	V	ViroGates A/S CSE:VIRO	Average EV/IC: 5 8.5
US		Abbott Laboratories NYSE:ABT	3.4
US		Intuitive Surgical Inc NASDAQ:ISRG	13.7
US		Stryker Corp NYSE:SYK	3.9
US		Boston Scientific Corp NYSE:BSX	3.8
IE		Medtronic PLC NYSE:MDT	1.7
US		Becton Dickinson and Co NYSE:BDX	1.8
DE		Siemens Healthineers AG XETRA:SHL	1.6
CN		Shenzhen Mindray Bio-Medical Electronics Co Ltd SZSE:300760	8.8
US		GE Healthcare Technologies Inc NASDAQ:GEHC	1.7
US		Edwards Lifesciences Corp NYSE:EW	5.7

EV/IC Forward Multiples

Forward EV/IC multiple is a version of the EV/IC ratio that uses forecasted invested capital for the EV/IC calculation. 1-Year, 2-Years, and 3-Years forwards use invested capital forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/IC

N/A

2-Years Forward

EV/IC

N/A

3-Years Forward

EV/IC

N/A

ViroGates A/S
CSE:VIRO

EV/IC
Enterprise Value to IC

EV/IC Forward Multiples

See Also

Company

Help

Tools

Stocks

ViroGates A/S CSE:VIRO

EV/IC Enterprise Value to IC

EV/IC Forward Multiples

See Also

Company

Help

Tools

Stocks

ViroGates A/S
CSE:VIRO

EV/IC
Enterprise Value to IC